[{"NetIncomeLoss_2_Q2_USD":-58439000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":10104000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":1.18,"GeneralAndAdministrativeExpense_2_Q2_USD":23174000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14195000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":1.18,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-210000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":298310000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-17622000.0,"Depreciation_2_Q2_USD":1100000.0,"Depreciation_1_Q2_USD":700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":8270387.0,"ConstructionInProgressGross_0_Q2_USD":22600000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":73000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":43000.0,"AssetsCurrent_0_Q2_USD":574461000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2778000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":11.57,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"ContractualObligation_0_Q2_USD":43000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.74,"DeferredCosts_0_Q2_USD":0.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":10654850.0,"Assets_0_Q2_USD":672670000.0,"CommonStockSharesIssued_0_Q2_shares":128743123.0,"LeaseAndRentalExpense_1_Q2_USD":800000.0,"LeaseAndRentalExpense_2_Q2_USD":1200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":19863690.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":8557000.0,"AccrualForTaxesOtherThanIncomeTaxesCurrent_0_Q2_USD":226000.0,"ConstructionPayableCurrent_0_Q2_USD":4753000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":566725000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":1531000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":35610000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21186000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":4.38,"EarningsPerShareBasic_2_Q2_USD":-0.71,"EarningsPerShareBasic_1_Q2_USD":-0.27,"TemporaryEquityLiquidationPreference_0_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-259000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":10000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":82478284.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":128743123.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-363000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-159000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":1988000.0,"GrantsReceivableCurrent_0_Q2_USD":887000.0,"CommonStockValue_0_Q2_USD":0.0,"OtherReceivablesNetCurrent_0_Q2_USD":397000.0,"OtherAssetsNoncurrent_0_Q2_USD":3807000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1995000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-35268000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-58366000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":1015000.0,"Liabilities_0_Q2_USD":37198000.0,"OtherAssetsCurrent_0_Q2_USD":0.0,"RestrictedCash_0_Q2_USD":50000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-37000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":392845000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-45000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1095000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_2_Q2_USD":-37000.0,"ConversionOfStockAmountConverted1_2_Q2_USD":384426000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-58802000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-35470000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5745000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2_Q2_shares":8660000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-49953000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":82478284.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":128743123.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":2104000.0,"LiabilitiesCurrent_0_Q2_USD":23844000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":325270000.0,"AccountsPayableCurrent_0_Q2_USD":5225000.0,"NonoperatingIncomeExpense_2_Q2_USD":-18000.0,"NonoperatingIncomeExpense_1_Q2_USD":-89000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":566775000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7736000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1438000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":41493000.0,"NetIncomeLoss_1_Q2_USD":-35311000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":78576000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":41493000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-69000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":10136000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":52460000.0,"Goodwill_0_Q2_USD":5722000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":9634000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":3690620.0,"AdditionalPaidInCapital_0_Q2_USD":739044000.0,"StockIssued1_2_Q2_USD":0.0,"SecurityDeposit_0_Q2_USD":99000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":158000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":2110000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":1810000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1348000.0,"OperatingIncomeLoss_2_Q2_USD":-58784000.0,"OperatingIncomeLoss_1_Q2_USD":-35381000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":10654850.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":339016000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":12240000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.25,"DeferredRentReceivablesNetNoncurrent_0_Q2_USD":2183000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.39,"LiabilitiesAndStockholdersEquity_0_Q2_USD":672670000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":6428000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8557000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5745000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_2_Q2_pure":0.05,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":70800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":48000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":79924000.0,"OperatingExpenses_2_Q2_USD":58784000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":2120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":2286626.0,"RestrictedCashNoncurrent_0_Q2_USD":50000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.27,"EarningsPerShareDiluted_2_Q2_USD":-0.71,"CommonStockSharesOutstanding_0_Q2_shares":128743123.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q2_shares":12854437.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-103362000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":19863690.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":17622000.0,"StockholdersEquity_0_Q2_USD":635472000.0,"OtherLiabilitiesCurrent_0_Q2_USD":193000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1108000.0,"OperatingExpenses_1_Q2_USD":35381000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2286626.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":9301000.0,"Ticker":"TIL","CIK":"1789769","name":"INSTIL BIO, INC.","OfficialName":"Instil Bio Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1149731379.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]